Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000296

Drug Information
SynonymsCHEBI:8430; SPBio_001331; p-Aminobenzoyldiethylaminoethanol; DivK1c_000120; CID4914; Gerovital; Procaine [INN:BAN]; beta-(Diethylamino)ethyl p-aminobenzoate; p-Aminobenzyoyldiethylaminoethanol; Scurocaine; AC1Q2ZE2; Procaina; Nissocaine; 91484-72-9; beta-Diethylaminoethyl 4-aminobenzoate; Jenacaine; KBioSS_001318; I06-1439; KBioGR_000975; Vitamin H3; Norocaine; AKOS000115407; IDI1_000120; MolPort-000-889-177; 4-14-00-01138 (Beilstein Handbook Reference); 2-Diethylaminoethyl p-aminobenzoate; 4-Aminobenzoic acid 2-(diethylamino) ethyl ester; 2-(Diethylamino)ethyl 4-aminobenzoate; procaine; Novocain; Procaine, base; 4-Aminobenzoic acid diethylaminoethyl ester; .beta.-Diethylaminoethyl 4-aminobenzoate; Spectrum4_000488; CHEMBL569; BRD-K24616672-003-05-2; BSPBio_000161; AB00053531; LS-35778; Spinocaine; Anticort; CAS-51-05-8; Diethylaminoethyl p-aminobenzoate; Stoff H3; Prestwick3_000041; InChI=1/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H; SP01A; DB00721; Spectrum2_001296; SP-01A; KBio2_003886; C07375; 2-Diethylaminoethylester kyseliny p-aminobenzoove [Czech]; Spectrum5_001186; Gerokit; KBio3_001731; Procaine (INN); SPBio_002082; STOCK2S-12721; BPBio1_000179; NINDS_000120; Duracaine; NCGC00015864-02; Benzoic acid, p-amino-, 2-(diethylamino)ethyl ester; Procainum [INN-Latin]; beta-(Diethylamino)ethyl 4-aminobenzoate; Anuject; 2-Diethylaminoethylester kyseliny p-aminobenzoove; Anticort (TM); BSPBio_002231; Gerovital H-3; Prestwick1_000041; SP01; KBio2_001318; Factor H3; 59-46-1; KBio1_000120; Spectrum3_000556; HSDB 3388; Solution of novocain (TN); 4-Aminobenzoesaeure-beta-diethylaminoethylester; KBio2_006454; NCGC00162298-01; Lopac0_000966; UNII-4Z8Y51M438; D08422; NSC 169497; Jenacain; Allocaine; NSC169497; 2-(Diethylamino)ethyl-4-aminobenzoate; Procainum; p-Aminobenzoic acid 2-diethylaminoethyl ester; WLN: ZR DVO2N2&2; NCGC00015864-04; Spectrum_000838; Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester; Lopac-P-9879; Prestwick2_000041; NCGC00015864-01; AC1L1J8C; 2-(Diethylamino)ethyl p-aminobenzoate; 2-Diethylaminoethyl 4-aminobenzoate; Prestwick0_000041; Solution of novocain; BENZOIC ACID,4-AMINO,2-DIETHYLAMINOETHYL ESTER PROCAIN BASE; BRN 0913480; Procain; .beta.-(Diethylamino)ethyl p-aminobenzoate; STK177303; EINECS 200-426-9; Procaina [INN-Spanish]; Novocaine
Trade NameNovocain
CompanyWyeth Pharmaceuticals
[ICD9: 338   ICD10: R52]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCCN(CC)CCOC(=O)C1=CC=C(C=C1)N    
Therapeutic ClassAnesthetics
CAS NumberCAS 59-46-1
PubChem Compound IDCID 4914.
PubChem Substance IDSID 9579.
SuperDrug ATC IDC05AD05; N01BA02; S01HA05
SuperDrug CAS ID000059461;
Target5-hydroxytryptamine receptor 3AAntagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 080658 To Reference
Ref 2Local anesthetics have different mechanisms and sites of action at recombinant 5-HT3 receptors. Reg Anesth Pain Med. 2007 Nov-Dec;32(6):462-70. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543